These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

907 related articles for article (PubMed ID: 31641008)

  • 1. A TAZ-ANGPTL4-NOX2 Axis Regulates Ferroptotic Cell Death and Chemoresistance in Epithelial Ovarian Cancer.
    Yang WH; Huang Z; Wu J; Ding CC; Murphy SK; Chi JT
    Mol Cancer Res; 2020 Jan; 18(1):79-90. PubMed ID: 31641008
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Hippo Pathway Effector TAZ Regulates Ferroptosis in Renal Cell Carcinoma.
    Yang WH; Ding CC; Sun T; Rupprecht G; Lin CC; Hsu D; Chi JT
    Cell Rep; 2019 Sep; 28(10):2501-2508.e4. PubMed ID: 31484063
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hippo pathway effectors YAP/TAZ as novel determinants of ferroptosis.
    Yang WH; Chi JT
    Mol Cell Oncol; 2020; 7(1):1699375. PubMed ID: 31993503
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Roles of YAP/TAZ in ferroptosis.
    Magesh S; Cai D
    Trends Cell Biol; 2022 Sep; 32(9):729-732. PubMed ID: 35701310
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TAZ Regulates the Cisplatin Resistance of Epithelial Ovarian Cancer Cells via the ANGPTL4/SOX2 Axis.
    Li C; Wang Q; Luo Y; Xiang J
    Anal Cell Pathol (Amst); 2022; 2022():5632164. PubMed ID: 36247876
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of ferroptosis in cancer cells by YAP/TAZ and Hippo pathways: The therapeutic implications.
    Sun T; Chi JT
    Genes Dis; 2021 May; 8(3):241-249. PubMed ID: 33997171
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Hippo Pathway Effector YAP Promotes Ferroptosis via the E3 Ligase SKP2.
    Yang WH; Lin CC; Wu J; Chao PY; Chen K; Chen PH; Chi JT
    Mol Cancer Res; 2021 Jun; 19(6):1005-1014. PubMed ID: 33707306
    [TBL] [Abstract][Full Text] [Related]  

  • 8. YAP/TAZ-mediated regulation of laminin 332 is enabled by β4 integrin repression of ZEB1 to promote ferroptosis resistance.
    Goel HL; Karner ER; Kumar A; Mukhopadhyay D; Goel S; Mercurio AM
    J Biol Chem; 2024 Apr; 300(4):107202. PubMed ID: 38508310
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel role for microRNA-129-5p in inhibiting ovarian cancer cell proliferation and survival via direct suppression of transcriptional co-activators YAP and TAZ.
    Tan G; Cao X; Dai Q; Zhang B; Huang J; Xiong S; Zhang Yy; Chen W; Yang J; Li H
    Oncotarget; 2015 Apr; 6(11):8676-86. PubMed ID: 25895125
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypoxic conditions differentially regulate TAZ and YAP in cancer cells.
    Yan L; Cai Q; Xu Y
    Arch Biochem Biophys; 2014 Nov; 562():31-6. PubMed ID: 25078107
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New insights into the ambivalent role of YAP/TAZ in human cancers.
    Luo J; Deng L; Zou H; Guo Y; Tong T; Huang M; Ling G; Li P
    J Exp Clin Cancer Res; 2023 May; 42(1):130. PubMed ID: 37211598
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Division of Labor between YAP and TAZ in Non-Small Cell Lung Cancer.
    Shreberk-Shaked M; Dassa B; Sinha S; Di Agostino S; Azuri I; Mukherjee S; Aylon Y; Blandino G; Ruppin E; Oren M
    Cancer Res; 2020 Oct; 80(19):4145-4157. PubMed ID: 32816858
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An Imbalance in TAZ and YAP Expression in Hepatocellular Carcinoma Confers Cancer Stem Cell-like Behaviors Contributing to Disease Progression.
    Hayashi H; Higashi T; Yokoyama N; Kaida T; Sakamoto K; Fukushima Y; Ishimoto T; Kuroki H; Nitta H; Hashimoto D; Chikamoto A; Oki E; Beppu T; Baba H
    Cancer Res; 2015 Nov; 75(22):4985-97. PubMed ID: 26420216
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TAZ Protein Accumulation Is Negatively Regulated by YAP Abundance in Mammalian Cells.
    Finch-Edmondson ML; Strauss RP; Passman AM; Sudol M; Yeoh GC; Callus BA
    J Biol Chem; 2015 Nov; 290(46):27928-38. PubMed ID: 26432639
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Non-hippo kinases: indispensable roles in YAP/TAZ signaling and implications in cancer therapy.
    Zhu J; Wu T; Lin Q
    Mol Biol Rep; 2023 May; 50(5):4565-4578. PubMed ID: 36877351
    [TBL] [Abstract][Full Text] [Related]  

  • 16. YAP/TAZ and ATF4 drive resistance to Sorafenib in hepatocellular carcinoma by preventing ferroptosis.
    Gao R; Kalathur RKR; Coto-Llerena M; Ercan C; Buechel D; Shuang S; Piscuoglio S; Dill MT; Camargo FD; Christofori G; Tang F
    EMBO Mol Med; 2021 Dec; 13(12):e14351. PubMed ID: 34664408
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-cancer effects of nitazoxanide in epithelial ovarian cancer in-vitro and in-vivo.
    Yang X; Liu Z; Wang X; Tian W; Zhao T; Yang Q; Li W; Yang L; Yang H; Jia Y
    Chem Biol Interact; 2024 Sep; 400():111176. PubMed ID: 39084502
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DDR2 upregulation confers ferroptosis susceptibility of recurrent breast tumors through the Hippo pathway.
    Lin CC; Yang WH; Lin YT; Tang X; Chen PH; Ding CC; Qu DC; Alvarez JV; Chi JT
    Oncogene; 2021 Mar; 40(11):2018-2034. PubMed ID: 33603168
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Hippo Effector Transcriptional Coactivator with PDZ-Binding Motif Cooperates with Oncogenic β-Catenin to Induce Hepatoblastoma Development in Mice and Humans.
    Zhang S; Zhang J; Evert K; Li X; Liu P; Kiss A; Schaff Z; Ament C; Zhang Y; Serra M; Evert M; Chen N; Xu F; Chen X; Tao J; Calvisi DF; Cigliano A
    Am J Pathol; 2020 Jul; 190(7):1397-1413. PubMed ID: 32283103
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overexpression of TAZ promotes cell proliferation, migration and epithelial-mesenchymal transition in ovarian cancer.
    Chen G; Xie J; Huang P; Yang Z
    Oncol Lett; 2016 Sep; 12(3):1821-1825. PubMed ID: 27588129
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 46.